Aramark

For the period ended Jun 28, 2024. Filed Aug 6, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 28, 2024 · Filed Aug 6, 2024

ARMK$54.22-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Cash Flows

	Nine Months Ended
	June 28, 2024	June 30, 2023
Cash flows from operating activities of Continuing Operations:
Net income from Continuing Operations	$139,640	$338,765
Adjustments to reconcile Net income from Continuing Operations to Net cash used in operating activities of Continuing Operations
Depreciation and amortization	322,794	307,083
Asset write-downs	—	27,781
Reduction of contingent consideration liability (see Note 14)	—	(73,891)
Gain on sale of equity investments, net	—	(375,972)
Deferred income taxes	(11,948)	89,760
Share-based compensation expense	46,895	56,872
Changes in operating assets and liabilities
Receivables	(236,390)	(178,606)
Inventories	27,632	(7,438)
Prepayments and Other Current Assets	(3,548)	(16,449)
Accounts Payable	(224,211)	(274,844)
Accrued Expenses	(353,730)	(246,933)
Payments made to clients on contracts	(108,262)	(103,798)
Other operating activities	106,027	42,663
Net cash used in operating activities of Continuing Operations	(295,101)	(415,007)
Cash flows from investing activities of Continuing Operations:
Purchases of property and equipment and other	(288,140)	(258,585)
Disposals of property and equipment	17,228	12,956
Purchases of marketable securities	(71,215)	(69,998)
Proceeds from marketable securities	71,215	40,000
Acquisition of certain businesses, net of cash acquired	(106,334)	(49,503)
Proceeds from sale of equity investments	—	633,179
Other investing activities	(2,158)	15,455
Net cash (used in) provided by investing activities of Continuing Operations	(379,404)	323,504
Cash flows from financing activities of Continuing Operations:
Proceeds from long-term borrowings	298,329	1,550,886
Payments of long-term borrowings	(1,591,906)	(1,807,652)
Net change in funding under the Receivables Facility	599,000	395,065
Payments of dividends	(74,853)	(85,898)
Proceeds from issuance of common stock	24,872	42,343
Other financing activities	(56,006)	(18,578)
Net cash (used in) provided by financing activities of Continuing Operations	(800,564)	76,166
Discontinued Operations:
Net cash provided by operating activities	—	144,914
Net cash used in investing activities	—	(41,598)
Net cash used in financing activities	—	(19,431)
Net cash provided by Discontinued Operations	—	83,885
Effect of foreign exchange rates on cash and cash equivalents and restricted cash	(1,769)	13,268
(Decrease) Increase in cash and cash equivalents and restricted cash	(1,476,838)	81,816
Cash and cash equivalents and restricted cash, beginning of period	1,972,367	365,431
Cash and cash equivalents and restricted cash, end of period	$495,529	$447,247

Supplemental disclosure of cash flow information	Nine Months Ended
(in millions)	June 28, 2024	June 30, 2023
Interest paid	$267.3	$322.2
Income taxes paid	90.3	37.3

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the condensed consolidated Balance Sheets:

Balance Sheet classification
(in thousands)	June 28, 2024	June 30, 2023
Cash and cash equivalents	$436,075	$388,166
Restricted cash in Prepayments and other current assets	59,454	44,833
Cash and cash equivalents in Current assets of discontinued operations	—	14,248
Total cash and cash equivalents and restricted cash	$495,529	$447,247

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.